CVS Health Past Earnings Performance
Past criteria checks 1/6
CVS Health's earnings have been declining at an average annual rate of -2.8%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 8.4% per year. CVS Health's return on equity is 6.7%, and it has net margins of 1.4%.
Key information
-2.8%
Earnings growth rate
-2.4%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 8.4% |
Return on equity | 6.7% |
Net Margin | 1.4% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings
Nov 19CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07Revenue & Expenses Breakdown
How CVS Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 367,246 | 5,016 | 41,181 | 0 |
30 Jun 24 | 361,855 | 7,190 | 40,454 | 0 |
31 Mar 24 | 359,662 | 7,321 | 39,898 | 0 |
31 Dec 23 | 356,623 | 8,344 | 39,205 | 0 |
30 Sep 23 | 346,601 | 8,632 | 38,790 | 0 |
30 Jun 23 | 338,072 | 2,965 | 38,629 | 0 |
31 Mar 23 | 329,915 | 4,093 | 38,135 | 0 |
31 Dec 22 | 321,629 | 4,311 | 37,922 | 0 |
30 Sep 22 | 314,343 | 3,283 | 37,970 | 0 |
30 Jun 22 | 306,933 | 8,287 | 37,549 | 0 |
31 Mar 22 | 298,770 | 8,041 | 37,252 | 0 |
31 Dec 21 | 290,912 | 8,001 | 36,764 | 0 |
30 Sep 21 | 283,981 | 7,586 | 36,046 | 0 |
30 Jun 21 | 277,285 | 7,212 | 35,270 | 0 |
31 Mar 21 | 270,115 | 7,404 | 34,972 | 0 |
31 Dec 20 | 267,908 | 7,188 | 34,585 | 0 |
30 Sep 20 | 265,285 | 7,951 | 33,907 | 0 |
30 Jun 20 | 262,980 | 8,257 | 33,881 | 0 |
31 Mar 20 | 260,961 | 7,217 | 33,226 | 0 |
31 Dec 19 | 255,765 | 6,629 | 32,699 | 0 |
30 Sep 19 | 243,331 | 4,464 | 30,515 | 0 |
30 Jun 19 | 226,053 | 4,324 | 27,032 | 0 |
31 Mar 19 | 209,623 | -174 | 23,924 | 0 |
31 Dec 18 | 193,919 | -597 | 20,827 | 0 |
30 Sep 18 | 188,055 | 3,098 | 33,284 | 0 |
30 Jun 18 | 186,967 | 2,989 | 28,379 | 0 |
31 Mar 18 | 185,944 | 6,645 | 18,987 | 0 |
31 Dec 17 | 184,765 | 6,606 | 18,737 | 0 |
30 Sep 17 | 182,351 | 5,029 | 4,607 | 0 |
30 Jun 17 | 180,785 | 5,281 | 9,215 | 0 |
31 Mar 17 | 178,825 | 5,108 | 18,362 | 0 |
31 Dec 16 | 177,526 | 5,291 | 18,284 | 0 |
30 Sep 16 | 172,701 | 5,084 | 18,102 | 0 |
30 Jun 16 | 166,729 | 4,781 | 17,677 | 0 |
31 Mar 16 | 160,173 | 5,126 | 17,234 | 0 |
31 Dec 15 | 153,290 | 5,202 | 16,833 | 0 |
30 Sep 15 | 149,199 | 5,027 | 16,673 | 0 |
30 Jun 15 | 145,577 | 4,741 | 16,712 | 0 |
31 Mar 15 | 143,010 | 4,713 | 16,688 | 0 |
31 Dec 14 | 139,367 | 4,626 | 16,543 | 0 |
30 Sep 14 | 135,142 | 4,576 | 16,378 | 0 |
30 Jun 14 | 132,053 | 4,887 | 16,100 | 0 |
31 Mar 14 | 128,699 | 4,775 | 15,853 | 0 |
31 Dec 13 | 126,761 | 4,600 | 15,818 | 0 |
Quality Earnings: CVS has high quality earnings.
Growing Profit Margin: CVS's current net profit margins (1.4%) are lower than last year (2.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CVS's earnings have declined by 2.8% per year over the past 5 years.
Accelerating Growth: CVS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CVS had negative earnings growth (-41.9%) over the past year, making it difficult to compare to the Healthcare industry average (10.4%).
Return on Equity
High ROE: CVS's Return on Equity (6.7%) is considered low.